![](https://u0gb50.p3cdn1.secureserver.net/wp-content/uploads/2023/08/genentech2-2815589735-150x150.jpg)
South San Francisco, CA October 4, 2023 Press Release Majority of Newborn Babies With Spinal Muscular Atrophy (SMA) Treated With Genentech’s Evrysdi Able to Sit Independently After 1 Year of Treatment RAINBOWFISH study met its primary endpoint with 80% of…